IMC - Immuron Limited - Strawman: ASX share price, valuation, research and discussion

Top member reports

Company Report

Last edited 4 years ago

Performance (46m)

-8.0% pa

Followed by

616

Straws

Sort by:

Recent

Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.

Become a member

#ASX Announcements

stale

Added 4 years ago

Immuron Reports Neutralizing activity Against SARS-CoV-2

Key Points

* Immuron’s IMM-124E used to manufacture Travelan® and Protectyn® demonstrates antiviral activity against the COVID-19 virus in laboratory studies

* Immuron’s technology platform offers a potential new oral therapeutic approach to target SARS-CoV-2 in the GI Tract

Immuron Limited